FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)
CUSIP: 31447P100
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common stock, no par value (the "Shares")
- Shares outstanding
- 34,145,841
- Total 13F shares
- 6,949,133
- Share change
- +1,801,188
- Total reported value
- $69,588,032
- Price per share
- $10.00
- Number of holders
- 16
- Value change
- +$18,006,732
- Number of buys
- 13
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
3,997,214
|
$44,329,000 | — | 30 Sep 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
2.4%
|
808,365
|
$8,867,000 | — | 30 Sep 2017 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.73%
|
250,000
|
$2,773,000 | — | 30 Sep 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.2%
|
66,666
|
$731,000 | — | 30 Sep 2017 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.15%
|
49,593
|
$550,000 | — | 30 Sep 2017 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.12%
|
41,140
|
$456,000 | — | 30 Sep 2017 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0%
|
1,150
|
$12,000 | — | 30 Sep 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
400
|
$4,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
79
|
$1,000 | — | 30 Sep 2017 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
4
|
$43 | — | 30 Sep 2017 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q4 2017
As of 31 Dec 2017,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,949,133 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, 683 Capital Management, LLC, Opaleye Management Inc., EVENTIDE ASSET MANAGEMENT, LLC, ACUTA CAPITAL PARTNERS, LLC, PUTNAM INVESTMENTS LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, UNITED SERVICES AUTOMOBILE ASSOCIATION, Cardinal Capital Management, and Hartford Financial Management Inc..
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
10
Q4 2017 holders
16
Holder diff
6
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.